Strong FY25/26 trading and why it matters for A.G. Barr shareholders
A.G. Barr has delivered a tidy trading update for the year to 31 January 2026, with performance in-line with expectations and double-digit profit growth on an adjusted basis. Revenue ticked up to around £437 million, margins moved higher, and the group has struck two notable deals in the premium adult soft drinks space – Fentimans and Frobishers.
The message is clear: steady operational delivery, improving efficiency, and a bigger brand portfolio aimed at higher-value occasions. With final results due on 31 March 2026, this update sets a constructive tone for FY26/27.
Headline numbers – revenue up and margins higher
Top line grew by about 4% to roughly £437 million, from £420 million the year before, with adjusted operating margin stepping up to around 14.7% from 13.6% – an improvement of approximately 110 basis points (1.10 percentage points). That margin expansion, supported by efficiency initiatives and supply chain investment, underpins double-digit growth in adjusted profit before tax.
Adjusted Return on Capital Employed held at about 20%, which is the company’s target level. It is worth noting this year was a 53-week period; the company says the year-on-year metrics reflect the full FY25/26 53 weeks compared with FY24/25.
| Metric | FY24/25 | FY25/26 | Change |
|---|---|---|---|
| Revenue | £420m | c.£437m | c.+4% |
| Adjusted operating margin | 13.6% | c.14.7% | c.+110 bps |
| Adjusted profit before tax | Not disclosed | Double-digit growth | Positive |
| Adjusted ROCE | Target c.20% | Maintained c.20% | Stable |
What drove the margin expansion?
Barr points to ongoing efficiency initiatives and supply chain investment as the main supports. The company also highlights continued capital investment in manufacturing sites, improving both capacity and capability, delivered on time and on budget. Put simply, they have been tightening operations and it is showing up in the numbers.
Brand performance – IRN-BRU steady, Rubicon and Boost stronger, FUNKIN softer
Brand momentum was mixed but broadly positive:
- IRN-BRU – modest growth in the second half after a flat first half, helped by marketing and distribution initiatives.
- Rubicon and Boost – described as delivering good performances.
- FUNKIN – declined over the year.
- Innovation – significantly expanded, with multiple new launches starting from January 2026.
That blend suggests the core portfolio is resilient, innovation is ramping up, and there is work to do in the cocktail mixer segment, where FUNKIN dipped. The upcoming redesigns of IRN-BRU and Rubicon in FY26/27 should keep the brands front-of-shelf.
Strategic moves – acquiring Fentimans and Frobishers
Barr is leaning into the Adult Soft Drinks category, which benefits from the ongoing trend of reduced alcohol consumption. The company has acquired two premium names:
- Frobishers Juices Ltd – acquired towards the end of the period for £13 million, funded from the company’s net cash position.
- Fentimans Ltd – completed after the year-end on 2 February 2026 for around £38 million, funded through a mix of cash and debt.
Both brands broaden Barr’s reach in premium adult occasions – Fentimans with its well-known “Botanical Brewing” soft drinks and mixers, Frobishers with premium natural fruit juices and soft drinks. Management expects cost synergies and notes integration will take place during FY26/27, with efficiencies beginning to come through from the second half.
Why these deals are interesting
- Category tailwind – Adult soft drinks are growing as consumers cut back on alcohol. These brands plug into that behaviour at premium price points.
- Portfolio fit – They complement IRN-BRU, Rubicon and Boost by adding more adult, mixer, and premium juice options.
- Synergies and accretion – Barr sees meaningful medium-term accretion from synergies. In plain English, they expect the deals to add to earnings over time as overlapping costs are taken out and scale benefits kick in.
Risks to watch: integration always demands focus, and the Fentimans deal introduces some debt (amount not disclosed). There is also execution risk in repositioning and scaling premium brands without diluting their distinctiveness. That said, Barr’s margin discipline and c.20% adjusted ROCE provide a reassuring backdrop.
Outlook for FY26/27 – momentum, integration, and brand refreshes
Management frames FY26/27 as a year of building momentum. The plan includes integrating Fentimans and Frobishers, delivering associated efficiencies from the second half, and pushing a strong brand activity pipeline. Notably, IRN-BRU and Rubicon will receive redesigns and further innovation launches are queued through the year.
Operationally, the company’s recent investment in manufacturing capacity and capability should continue to support service levels, innovation speed, and cost control. The next big date for investors is 31 March 2026, when full results will land.
The balanced view – positives and watchouts
- Positives – Revenue growth c.4%, margin up c.110 bps to c.14.7%, double-digit adjusted profit growth, and adjusted ROCE maintained at c.20% signal disciplined execution. The two acquisitions broaden the portfolio and position Barr for premium adult occasions.
- Watchouts – FUNKIN’s decline needs addressing, integration of two deals in quick succession adds complexity, and the Fentimans funding includes debt (not disclosed). The period also included 53 weeks, which is worth keeping in mind when comparing year-on-year revenue.
My take: this is a solid, well-signalled update. The strategy – tighten operations, invest in capacity, refresh core brands, and add targeted premium labels – makes sense. The proof point for FY26/27 will be delivery of integration synergies from H2 and visible traction from the innovation pipeline.
Quick reference – A.G. Barr FY25/26 at a glance
| Item | Detail |
|---|---|
| Revenue | c.£437m (up c.4% vs £420m) |
| Adjusted operating margin | c.14.7% (vs 13.6%, up c.110 bps) |
| Adjusted profit before tax | Double-digit growth (exact figure not disclosed) |
| Adjusted ROCE | Maintained at c.20% |
| IRN-BRU | Modest H2 growth after flat H1 |
| Rubicon and Boost | Good performances |
| FUNKIN | Declined |
| Frobishers acquisition | £13m, funded from net cash, completed towards period end |
| Fentimans acquisition | c.£38m, completed 2 February 2026, funded by cash and debt |
| Integration and synergies | FY26/27 integration; efficiencies expected from H2 |
| Upcoming catalysts | Final results 31 March 2026; IRN-BRU and Rubicon redesigns; further innovation launches |
Overall, A.G. Barr enters FY26/27 with a cleaner cost base, improving margins, and two fresh brands that target premium adult drinkers. Execution on integration and innovation will decide how much of that momentum converts into continued profit growth.